Lim Kin Sheng

Daas Arij, Patel Bhavin, Ranjit Ananth, Galvis Elizabeth Angela, Madekurozwa Michael, Amon Andrew et al.

MP-TSCPC reduces IOP in glaucoma/OHT primarily by decreasing aqueous humor production, not outflow. This clarifies its mechanism, supporting its safe, effective use.

Lim Kin Sheng, García-Feijóo Julián, Klabe Karsten

This review and expert panel recommend PRESERFLO MicroShunt for most uncontrolled open-angle glaucoma patients, offering guidance on patient selection, pre/peri/post-operative care, and essential surgical techniques for optimizing outcomes.

Kolko Miriam, Tatham Andrew J, Lim Kin Sheng, Wells Anthony P, Shiu Michael, Uy Harvey S et al.

This study found the bimatoprost implant noninferior to SLT for lowering IOP in glaucoma patients. Both offered sustained IOP reduction, with flexible implant retreatment improving safety, providing alternative treatment options.

King Anthony J, Hudson Jemma, Azuara-Blanco Augusto, Kirwan James F, Goyal Saurabh, Lim Kin Sheng et al.

Socioeconomic status correlated with worse baseline visual function and later diagnosis in advanced glaucoma patients, but did not affect treatment success at 24 months, suggesting equitable treatment outcomes regardless of SES.

Stalmans Ingeborg, Lim Kin Sheng, Oddone Francesco, Fichtl Marek, Belda Jose I, Hommer Anton et al.

This study found netarsudil/latanoprost was non-inferior to bimatoprost/timolol in lowering IOP for glaucoma/ocular hypertension. It offers an effective alternative fixed-dose combination, though with different side effect profiles.

Gedde Steven J, Feuer William J, Lim Kin Sheng, Barton Keith, Goyal Saurabh, Ahmed Iqbal I et al.

The PTVT study found trabeculectomy had more early complications than tube shunts for glaucoma. However, serious complications, late complications, and cataract progression were similar between groups over five years.

Gedde Steven J, Feuer William J, Lim Kin Sheng, Barton Keith, Goyal Saurabh, Ahmed Iqbal I et al.

This 5-year study found trabeculectomy and tube shunts similarly controlled IOP in primary glaucoma, but trabeculectomy required fewer medications, guiding surgical choice.

Daas Arij, Sherman Thomas, Danieliute Lina, Goyal Saurabh, Amon Andrew, Rodrigues Ian et al.

Combining cataract surgery with micropulse cyclodiode laser effectively reduced IOP and glaucoma medication use, offering a safe, combined treatment for glaucoma patients.

Nagar Anindyt, Daas Arij, Danieliute Lina, Alaghband Pouya, Yu-Wai-Man Cynthia, Amon Andrew et al.

HiFU for glaucoma reduced IOP at 12 months by decreasing aqueous humor flow, not by altering outflow facility or uveoscleral outflow, clarifying its mechanism.

Ho Henrietta, Daas Arij, Ho Jason, Alaghband Pouya, Galvis Elizabeth Angela, de Antonio Ramirez Alba et al.

This study found that after glaucoma medication washout, uveitic glaucoma patients had a smaller IOP increase than POAG/OHT patients, suggesting washout may be considered for controlled uveitic glaucoma.

Alaghband Pouya, Galvis Elizabeth Angela, Daas Arij, Nagar Anindyt, Beltran-Agulló Laura, Khawaja Anthony P et al.

This study found that higher baseline intraocular pressure, not outflow facility, is the sole predictor of success after primary selective laser trabeculoplasty in treatment-naïve glaucoma/ocular hypertension patients.

Gedde Steven J, Feuer William J, Lim Kin Sheng, Barton Keith, Goyal Saurabh, Ahmed Iqbal I K et al.

Comparing tube shunts and trabeculectomy for uncontrolled glaucoma, both had similar 3-year failure rates. Trabeculectomy achieved lower IOP with fewer medications, but serious complications were similar for both procedures.

Alaghband Pouya, Baneke Alexander Jan, Galvis Elizabeth, Madekurozwa Michael, Chu Brian, Stanford Miles et al.

This study found that elevated eye pressure in uveitic glaucoma/OHT is primarily caused by reduced aqueous outflow facility, not changes in aqueous humor production or uveoscleral outflow, guiding treatment.

Daas Arij, Ho Henrietta, Lim Kin Sheng

Grassi Piergiacomo, Ho Henrietta, Lim Kin Sheng

Ho Henrietta, Ho Jason, Rodrigues Ian, Syrimi Marina, Goyal Saurabh, Lim Kin Sheng

This study found reusable ECP probes significantly lower per-procedure costs compared to other MIGS in the UK, with costs decreasing further with increased use, making it a cost-effective glaucoma treatment.

Grassi Piergiacomo, Ho Henrietta, Lim Kin Sheng

Steven David W, Alaghband Pouya, Lim Kin Sheng

Despite known BAK toxicity, studies show no clear benefit of preservative-free glaucoma drops for all patients, but they are recommended for those with ocular surface disease or on multiple medications.

Grassi Piergiacomo, Ho Henrietta, Lim Kin Sheng

Alaghband Pouya, Beltran-Agulló Laura, Galvis Elizabeth Angela, Overby Darryl R, Lim Kin Sheng

Phacoemulsification significantly increased trabecular outflow facility, fully accounting for the observed intraocular pressure reduction, clarifying how cataract surgery lowers eye pressure.

Grassi Piergiacomo, Ho Henrietta, Lim Kin Sheng

Gedde Steven J, Feuer William J, Shi Wei, Lim Kin Sheng, Barton Keith, Goyal Saurabh et al.

Trabeculectomy with MMC achieved better IOP control and success than tube shunts at one year, but tube shunts had fewer serious complications, guiding initial surgical choice for uncontrolled glaucoma.

Lim Kin Sheng

This study reviewed glaucoma drainage devices' hypotony prevention strategies, finding most don't address late-stage flow resistance, except for the EyeWatch device, impacting surgical outcomes.

Beltran-Agullo Laura, Alaghband Pouya, Rashid Safina, Gosselin Josee, Obi Adanna, Husain Rahat et al.

This study found no significant differences in aqueous humor dynamics between Black and White glaucoma/OHT patients, but noted thinner corneas in Black patients, which might mask underlying differences.